reference/35008709

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35008709

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural
issn	2041-1723
issueIdentifier	1
pageRange	6623-
publicationName	Nature Communications
startingPage	6623
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_77e2488754b2b37f99f84e3d30d28ece http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_707beda69790424bde2fe82ed9dc29cf http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_adcde6a913dd36d65261bda0a9b8dc13 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_254651a6576ac543da71b7e1dc503243 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4ee426cf5bf87f4797bc79fab5031380 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_81ccf0c164d2897f29cac5a79d38b488 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a433f8d68d7d6df0b0bdd63e189d43ab
bibliographicCitation	Lu Z, Chen J, Yu P, Atherton MJ, Gui J, Tomar VS, Middleton JD, Sullivan NT, Singhal S, George SS, Woolfork AG, Weljie AM, Hai T, Eruslanov EB, Fuchs SY. Tumor factors stimulate lysosomal degradation of tumor antigens and undermine their cross-presentation in lung cancer. Nature Communications. 2022 Nov 04;13(1):6623. doi: 10.1038/s41467-022-34428-w.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3894-5697 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0743-5026 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7145-4494 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bec23859ebec25f644c379e5f84dd203 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0e84bd8c6ee067cf9855cb6d019804c5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9959-5566 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_902ff2c35aec20a8faa42acb950d1c0d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_09c5ae7136e6324220327a0e6b8a8a05 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4589-9182 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0136-5103 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9830-3151 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_84a335d80fe94c26b05b52652ee1bf4b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8022-1203 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3452-0528 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ea22e72063bc309f93bcabce80da3d1c
date	2022-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC9636202 https://doi.org/10.1038/s41467-022-34428-w https://pubmed.ncbi.nlm.nih.gov/36333297
isPartOf	https://portal.issn.org/resource/ISSN/2041-1723 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37539
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Tumor factors stimulate lysosomal degradation of tumor antigens and undermine their cross-presentation in lung cancer
discusses	http://id.nlm.nih.gov/mesh/M0001435
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/11 http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112 http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_45d050fd2e79810aac8989cbd4b5dfd5 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29f84c0d894769b14b36c5f43f54153e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b83d04d3e3b05ce10d1a5893dc850a9b http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_1.14.99.38 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5511de9f232e4b85f629fb2ebc9a2e5a http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23035251 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8366 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7045

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11910 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12642

Total number of triples: 56.